Dr. Bruno Carneiro De Medeiros, MD is a Hematology / Oncology Specialist - Hematologist (Blood) practicing in Palo Alto, CA
He has not yet shared a personalized biography with Doctor.com.
University | Degree | Focus | Graduated |
---|---|---|---|
Federal University of Parana | Medical Degree | Not Specified |
Institution | Focus | Year |
---|---|---|
Internship - University of Connecticut Health Center CT | 2000 | |
Internship - University of Connecticut Health Center | 2000 | |
Residency - University of Colorado Health Science Center | 2002 | |
Residency - University of Colorado Denver Affiliated Hospitals | 2002 | |
Fellowship - Acute leukemia, Princess Margaret Hospital - University of Toronto | 2006 | |
Fellowship - University of Colorado Health Science Center CO | 2005 | |
Fellowship - Acute leukemia, Princess Margaret Hospital - University of Toronto | 2006 |
Certification | Cert. Body | Year |
---|---|---|
Sub-Specialty: Hematology | Internal Medicine | 2006 |
Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
Internal medicine Sub-Specialty: Hematology | Internal Medicine | 2006 |
Internal medicine Sub-Specialty: Medical Oncology | Internal Medicine | 2005 |
Position | Organization | Time |
---|---|---|
Panel Member | Multiple Myeloma Committee, National Comprehensive Cancer Network | 2007 - 2011 |
Director | Stanford Hospital Hematology Inpatient service | 2011 - 2013 |
Director | Stanford Acute Leukemia Clinical Research Program | 2009 - 2013 |
Panel member | adult oncology committee, National comprehensive cancer network | 2010 - 2013 |
Acute Leukemia Panel Member | Southwest Oncology Group | 2007 - 2013 |
Assistant Professor of Medicine (Hematology) | the Stanford University Medical Center | Present |
Publication | Publisher | Title | Published |
---|---|---|---|
Other Publication | Proceedings of the tiol Academy of Sciences of the United States of Am | Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators | 2014 |
Other Publication | BRITISH JOURL OF HAEMATOLOGY | Unsuccessful diagnostic cytogenetic alysis is a poor prognostic feature in acute myeloid leukaemia | 2014 |
Other Publication | Haematologica | Sequential azacitidine plus lelidomide combition | 2013 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia | 2012 |
Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for | 2012 |
Other Publication | AMERICAN JOURL OF HEMATOLOGY | Tailored temozolomide therapy according to MGMT methylation status | 2012 |
Other Publication | NEW ENGLAND JOURL OF MEDICINE | Cytarabine Dose for Acute Myeloid Leukemia | 2011 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . | 2014 |
Other Publication | HAEMATOLOGICA | Gemtuzumab ozogamicin in combition with vorinostat | 2014 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Hematopoietic Stem Cell Transplantation for Hematologic Maligncies in Older Adults | 2014 |
Other Publication | Jourl of oncology practice / American Society of Clinical Oncology | Qualitative alysis of practicing oncologists' attitudes | 2013 |
Other Publication | Leukemia & lymphoma | A single-center experience of the tionwide daunorubicin shortage | 2013 |
Other Publication | Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C. | Amrubicin, a Novel Investigatiol Anthracycline | |
Other Publication | Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., Med | A Phase I/II Study of Bortezomib | |
Other Publication | HEMATOLOGY | Hemophagocytic lymphohistiocytosis in pregncy: a case report and review of treatment options | 2012 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Waldenstrom's Macroglobulinemia | 2012 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. | 2012 |
Other Publication | AMERICAN JOURL OF HEMATOLOGY | Absolute lymphocyte count at day 28 independently predicts event-free | 2012 |
Other Publication | INTERTIOL JOURL OF HEMATOLOGY | Novel agents in acute myeloid leukemia | 2012 |
Other Publication | JOURL OF GERIATRIC ONCOLOGY | New treatment approaches for older adults with multiple myeloma | 2012 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post | 2012 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Senior Adult Oncology | 2012 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Phase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B | 2012 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURL | Treatment advances have not improved the early death rate in acute promyelocytic leukemia | 2012 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2011 |
Other Publication | BRITISH JOURL OF HAEMATOLOGY | Acute myeloid leukaemia in the elderly: a review | 2011 |
Other Publication | LAB ON A CHIP | Microfluidic purification and alysis of hematopoietic stem cells from bone marrow | 2011 |
Other Publication | Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go | A Phase I Study of Sequential Azacitidine | 2010 |
Other Publication | AMERICAN JOURL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
Other Publication | Expert review of hematology | Plasma cell leukemia: concepts and magement. | 2010 |
Other Publication | EXPERT REVIEW OF HEMATOLOGY | Plasma cell leukemia: concepts and magement | 2010 |
Other Publication | AMERICAN JOURL OF HEMATOLOGY | Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with | 2010 |
Other Publication | Walter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, | PHASE 2 TRIAL OF VORINOSTAT | 2010 |
Other Publication | JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2009 |
Other Publication | AMERICAN JOURL OF HEMATOLOGY | Thalidomide-induced pneumonitis in a patient with plasma cell leukemia | 2009 |
Other Publication | Jourl of the tiol Comprehensive Cancer Network | NCCN clinical practice guidelines in oncology: multiple myeloma. | 2009 |
Other Publication | NEW ENGLAND JOURL OF MEDICINE | Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia | 2009 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Role of CEBPA in Normal Karyotype Acute Myeloid Leukemia | 2009 |
Other Publication | JOURL OF CLINICAL ONCOLOGY | Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia | 2009 |
Other Publication | Cases jourl | Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin | 2009 |
Other Publication | Proceedings of the National Academy of Sciences of the United States o | Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators | 2014 |
Other Publication | BRITISH JOURNAL OF HAEMATOLOGY | Unsuccessful diagnostic cytogenetic analysis is a poor prognostic feature | 2014 |
Other Publication | Haematologica | Sequential azacitidine plus lenalidomide combination | 2013 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia | 2012 |
Other Publication | BLOOD | Blood consult: monosomal karyotype acute myeloid leukemia | 2012 |
Other Publication | LEUKEMIA | Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide | 2012 |
Other Publication | CANCER | Impact of residual normal metaphases in core binding factor acute myeloid leukemia | 2012 |
Other Publication | Blood | Unveiling the complexity of CK+ AML. | 2012 |
Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Tailored temozolomide therapy according to MGMT methylation status | 2012 |
Other Publication | NEW ENGLAND JOURNAL OF MEDICINE | Cytarabine Dose for Acute Myeloid Leukemia | 2011 |
Other Publication | BLOOD | Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia | 2010 |
Other Publication | LEUKEMIA RESEARCH | Mcl-1 dependence predicts response to vorinostat | 2014 |
Other Publication | Journal of the National Comprehensive Cancer Network | Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . | 2014 |
Other Publication | Acta haematologica | Facts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia. | 2014 |
Other Publication | HAEMATOLOGICA | Gemtuzumab ozogamicin in combination with vorinostat | 2014 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Hematopoietic Stem Cell Transplantation for Hematologic Malignancies in Older Adults | 2014 |
Other Publication | Journal of oncology practice / American Society of Clinical Oncology | Qualitative analysis of practicing oncologists' attitudes | 2013 |
Other Publication | Leukemia & lymphoma | A single-center experience of the nationwide daunorubicin shortage | 2013 |
Other Publication | LEUKEMIA RESEARCH | CD11b expression and MK+ AML: A sign of impending doom? | 2013 |
Other Publication | LEUKEMIA & LYMPHOMA | 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia | 2013 |
Other Publication | LEUKEMIA | CD19(-)CD45(low/-)CD38(high)/CD138(+) plasma cells enrich for human tumorigenic myeloma cells | 2012 |
Other Publication | Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C. | Amrubicin, a Novel Investigational Anthracycline | |
Other Publication | Becker, P. S., Medeiros, B. C., Stein, A. S., Appelbaum, F. R., Scott, | Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine | |
Other Publication | Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., Med | A Phase I/II Study of Bortezomib | |
Other Publication | HEMATOLOGY | Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options | 2012 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Waldenstrom's Macroglobulinemia | 2012 |
Other Publication | Journal of the National Comprehensive Cancer Network | Waldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013. | 2012 |
Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Absolute lymphocyte count at day 28 independently predicts event-free | 2012 |
Other Publication | INTERNATIONAL JOURNAL OF HEMATOLOGY | Novel agents in acute myeloid leukemia | 2012 |
Other Publication | JOURNAL OF GERIATRIC ONCOLOGY | New treatment approaches for older adults with multiple myeloma | 2012 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post | 2012 |
Other Publication | APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY | Aggressive EBV-associated Lymphoproliferative Disorder | 2012 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Senior Adult Oncology | 2012 |
Other Publication | LEUKEMIA RESEARCH | It doesn't matter if you're black or white, does it? | 2012 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B | 2012 |
Other Publication | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | Treatment advances have not improved the early death rate in acute promyelocytic leukemia | 2012 |
Other Publication | Becker, P. S., Medeiros, B. C., Appelbaum, F. R., Scott, B. L., Hendri | Phase 2 Trial of G-CSF Priming, Clofarabine | 2011 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2011 |
Other Publication | EXPERT REVIEW OF HEMATOLOGY | Unfavorable-risk cytogenetics in acute myeloid leukemia | 2011 |
Other Publication | EXPERT OPINION ON THERAPEUTIC TARGETS | Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer | 2011 |
Other Publication | BRITISH JOURNAL OF HAEMATOLOGY | Acute myeloid leukaemia in the elderly: a review | 2011 |
Other Publication | LAB ON A CHIP | Microfluidic purification and analysis of hematopoietic stem cells from bone marrow | 2011 |
Other Publication | Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., Go | A Phase I Study of Sequential Azacitidine | 2010 |
Other Publication | Medeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., | Temozolomide In Acute Myeloid Leukemia | 2010 |
Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Second-line mitoxantrone, etoposide | 2010 |
Other Publication | Expert review of hematology | Plasma cell leukemia: concepts and management. | 2010 |
Other Publication | EXPERT REVIEW OF HEMATOLOGY | Plasma cell leukemia: concepts and management | 2010 |
Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with | 2010 |
Other Publication | Walter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, | PHASE 2 TRIAL OF VORINOSTAT | 2010 |
Other Publication | LEUKEMIA RESEARCH | Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2) | 2010 |
Other Publication | Alizadeh, A. A., McClellan, J. S., Gotlib, J. R., Coutre, S., Majeti, | Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported. | 2009 |
Other Publication | Kohrt, H. E., Patel, S., Ho, M., Owen, T., Majeti, R., Gotlib, J. R., | Is Time of the Essence in Adult Acute Myeloid Leukemia | 2009 |
Other Publication | JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | Multiple Myeloma | 2009 |
Other Publication | AMERICAN JOURNAL OF HEMATOLOGY | Thalidomide-induced pneumonitis in a patient with plasma cell leukemia | 2009 |
Other Publication | Journal of the National Comprehensive Cancer Network | NCCN clinical practice guidelines in oncology: multiple myeloma. | 2009 |
Other Publication | Medeiros, B. C., Gotlib, J. R., Coutre, S. E., Jones, C., Khan, S. A., | Interim results of protracted low doses of temozolomide in high-risk acute myeloid leukemia | |
Other Publication | NEW ENGLAND JOURNAL OF MEDICINE | Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Role of CEBPA in Normal Karyotype Acute Myeloid Leukemia | 2009 |
Other Publication | JOURNAL OF CLINICAL ONCOLOGY | Comparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia | 2009 |
Other Publication | McGuire, A., Shier, L. R., Gotlib, J., Medeiros, B., Wong, K., Corless | Myelomastocytic Leukemia: A Clinical, Pathologic, and Molecular Genetic Study | 2009 |
Other Publication | Cases journal | Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin | 2009 |
Dr. Bruno Carneiro De Medeiros, MD has not yet indicated the hospitals that he is affiliated with.
Accepts New Patients: Yes
Dr. Bruno Carneiro De Medeiros, MD has not yet listed the medications that he commonly prescribes.
Dr. Bruno Carneiro De Medeiros, MD has not yet added any information about his practice's billing policies and payment options.